Intrexon | XON - Trade Creditors

Stock Price
4.40
Daily Change
0.07 1.50%
Monthly
6.67%
Yearly
225.56%
Q2 Forecast
4.00

Intrexon reported $4.85M in Trade Creditors for its fiscal quarter ending in June of 2024.





Trade Creditors Change Date
Agenus USD 82.99M 2.3M Dec/2025
Alaunos Therapeutics USD 613K 230K Dec/2025
Amgen USD 19.52B 1.37B Mar/2026
Anika Therapeutics USD 6.34M 298K Mar/2026
Arrowhead Research USD 32.94M 15.26M Dec/2025
AstraZeneca USD 22.51B 2.78B Mar/2026
Bristol-Myers Squibb USD 4.23B 659M Mar/2026
Gilead Sciences USD 715M 93M Dec/2025
GlaxoSmithKline GBP 14.34B 1.05B Mar/2026
Heron Therapeutics USD 8.99M 3.02M Dec/2025
Incyte USD 228.62M 1.41B Mar/2026
Intrexon USD 4.85M 3.12M Jun/2024
Karyopharm Therapeutics USD 4M 1.39M Dec/2025
Ligand Pharmaceuticals USD 3.24M 24.52M Dec/2025
MacroGenics USD 4.79M 1.15M Dec/2025
MannKind USD 16.14M 7.11M Mar/2026
Merck USD 3.86B 541M Mar/2026
Novartis USD 4.32B 134M Mar/2026
Rigel Pharmaceuticals USD 3.85M 3.44M Sep/2025
Roche Holding CHF 5.78B 1.27B Dec/2025
Sangamo BioSciences USD 10.74M 7.46M Jun/2025
Thermo Fisher Scientific USD 3.34B 278M Mar/2026
Veracyte USD 6.91M 2.32M Mar/2026
Xencor USD 7.92M 2.91M Mar/2026